Vor Biopharma Inc is a clinical stage cell therapy company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 60.00% to -10 cents per share on November 07
Q3'25
Est.
$-0.10
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.10
Q3'24
Est.
$-0.40
The last earnings report on August 07 showed earnings per share of -25 cents, missing the estimate of -22 cents. With 208.31K shares outstanding, the current market capitalization sits at 244.50M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VOR showed earnings on August 07, 2025. You can read more about the earnings report here.